TABLE 1

Nucleotide sequences of the Sp1-like and mutant oligonucleotides used for EMSA


Oligonucleotidea

Sequenceb

Positionc
Sp D 5′–GGCGCAGCCCCCTCCCACGGCACCTTTCCA–3′ -193/-164
Sp Dmut 5′–GGCGCAGCCCCCTaaaACGGCACCTTTCCA–3′
Sp C 5′–AAGATGATGGGAGGGATTTAAAG–3′ -125/-103
Sp Cmut 5′–AAGATGATtttAGGGATTTAAAG–3′
Sp B 5′–AGGAGGAGGGTGTGGGCAGAAACA–3′ -72/-49
Sp Bmut 5′–AGGAGGAtttTGTGGGCAGAAACA–3′
Sp A 5′–CCTCTGCCCCACCACCCCCCAAG–3′ -36/-14
Sp Amut 5′–CCTCTGCCCCAaaAaCCCCCAAG–3′
Sp1/3
5′–ATTCGATCGGGGCGGGGCGAGC–3′
Consensus
  • a Single-stranded oligonucleotides were synthesized by IDT DNA. Oligonucleotides were resuspended (100 μM). Equal volumes of each oligonucleotide and its antisense oligonucleotide were annealed to form 50 μM double-stranded oligonucleotide, by heating to 95°C and then slowly cooling to RT. One picomole of double-stranded oligonucleotide probe was end-labeled with [γ-32P]ATP using T4 kinase. Sp1/3 is the sequence of a perfect consensus oligonucleotide supplied with the Promega gel shift system

  • b Putative Sp sites are in bold and underlined. Mutated nucleotides are lowercase

  • c Position of the oligonucleotides relative to the transcriptional start site